GlassScriptPhysician profile
Ira Henri Kraus
NPI 1588667075
$223,188.51
in general payments reported to CMS, 2019-2025
14 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90K · 2020: $20K · 2021: $91K · 2022: $9,414 · 2023: $12K · 2024: $1,546 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,200 · Travel and Lodging: $4,260 · Food and Beverage: $1,316 · Gift: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,200.00 |
| Travel and Lodging | $4,259.84 |
| Food and Beverage | $1,316.36 |
| Gift | $1,039.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $219,885.59 | 2019-2025 | Puraply Antimicrobial, Affinity, Puraply Wound Matrix |
| Iq Med LLC | $1,412.15 | 2022-2023 | |
| Collaborative Care Diagnostics, LLC | $622.65 | 2021-2024 | |
| Kerecis Limited | $579.61 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $255.04 | 2022-2024 | Grafix Pl, Stravix |
| Grt US Holding, INC. | $96.86 | 2022 | |
| Wright Medical Technology, INC. | $94.68 | 2019 | |
| Medline Industries LP | $93.57 | 2022 | |
| Averitas Pharma INC. | $58.00 | 2023 | Qutenza |
| Horizon Therapeutics Plc | $28.57 | 2019 | |
| Modulated Imaging, INC. | $24.91 | 2019 | |
| Cardiovascular Systems INC. | $24.38 | 2019 | |
| Aroa Biosurgery Incorporated | $12.50 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$115,270.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ira Kraus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.